Results 41 to 50 of about 4,297 (257)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa +7 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Is Einstein’s Special Relativity Wrong?
SSRN Electronic Journal, 2020 Einstein’s special relativity is incomplete. It is vogue at the speed of the light and does not present a correct value of the momentum in the spacetime. Hence, all formulas that have been extracted in the last century should be reviewed.
Kalhor, Bahram +2 more
openaire +1 more source
Tau acetylation at K331 has limited impact on tau pathology in vivo
FEBS Letters, EarlyView.We mapped tau post‐translational modifications in humanized MAPT knock‐in mice and in amyloid‐bearing double knock‐in mice. Acetylation within the repeat domain, particularly around K331, showed modest increases under amyloid pathology. To test functional relevance, we generated MAPTK331Q knock‐in mice.
Shoko Hashimoto +3 more
wiley +1 more source
Generalised Einstein mass-variation formulae: I Subluminal relative frame velocities
Results in Physics, 2016 Much of the formalism in special relativity is intimately bound up with Einstein’s formula for the variation of mass m with its velocity v, namely m(v)=m0∗[1-(v/c)2]-1/2, where m is the mass, v the velocity, c denotes the speed of light and m0∗ denotes ...
James M. Hill, Barry J. Cox
doaj +1 more source
"Mysteries" of modern physics and the fundamental constants c, h, and G
Quanta, 2022 We review how the kinematic structures of special relativity and quantum mechanics both stem from the relativity principle, i.e., "no preferred reference frame" (NPRF). Essentially, NPRF applied to the measurement of the speed of light c gives the light
W. M. Stuckey +2 more
doaj +1 more source
Gravitation and Special Relativity [PDF]
Journal of Dynamics and Differential Equations, 2013 29 pages, 1 ...
openaire +2 more sources
Quantum Entropy and Special Relativity [PDF]
Physical Review Letters, 2002 We consider a single free spin 1/2 particle. The reduced density matrix for its spin is not covariant under Lorentz transformations. The spin entropy is not a relativistic scalar and has no invariant meaning.
Peres, Asher +2 more
openaire +3 more sources
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source